[{"Assets_0_Q2_USD":117973000.0,"CommonStockSharesOutstanding_0_Q2_shares":32567485.0,"NetIncomeLoss_2_Q2_USD":-31504000.0,"NetIncomeLoss_1_Q2_USD":-9300000.0,"StockholdersEquity_0_Q2_USD":109220000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":29783424.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":32239877.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":29783424.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":32239877.0,"Ticker":"CARA","CIK":"1346830","name":"CARA THERAPEUTICS, INC.","OfficialName":"Cara Therapeutics Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"703167627.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170803"}]